China Pharmaceutical University;Jiangsu Kanion Pharmaceutical Co. Ltd
发明人:
Zhang, Mian,Xu, Xianghong,Xiang, Juan,Zhang, Chaofeng,He, Yanhui,Wu, Yan
申请号：
AU2015296400
公开号：
AU2015296400A1
申请日:
2015.06.17
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Disclosed is a new use of a compound as indicated in structural formula I in preparing medications for preventing and/or treating pulmonary fibrosis. The compound having the structure as indicated in structural formula 1 substantially reduces the inflammation of diseased lung tissue, lowers the concentration of fibrosis factors TGF-βΙ in diseased lung tissue, decreases the excessive deposition of collagen in diseased lung tissue, and has substantial prevention and treatment effectiveness against fibrosis.
